The store will not work correctly when cookies are disabled.
3-(4-Amino-phenyl)-2-(5-benzyl-1H-[1,2,4]triazol-3-yl)-acrylonitrile
ID: ALA117195
PubChem CID: 5869917
Max Phase: Preclinical
Molecular Formula: C20H19N5
Molecular Weight: 329.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1ccc(/C=C(\C#N)c2n[nH]c(Cc3ccccc3)n2)cc1
Standard InChI: InChI=1S/C20H19N5/c1-25(2)18-10-8-16(9-11-18)12-17(14-21)20-22-19(23-24-20)13-15-6-4-3-5-7-15/h3-12H,13H2,1-2H3,(H,22,23,24)/b17-12+
Standard InChI Key: DNVANFZUADSUPK-SFQUDFHCSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
5.2917 -3.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8792 -4.3625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1125 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7292 -3.0292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0667 -4.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9917 -3.3667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5917 -4.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4667 -2.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8167 -2.0667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0625 -4.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8792 -3.9417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4542 -4.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4167 -4.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7167 -4.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5792 -3.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7542 -3.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8917 -4.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6667 -4.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3625 -4.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2250 -3.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5042 -3.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0625 -5.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2792 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7250 -3.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1042 -3.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 2 0
5 2 2 0
6 4 1 0
7 3 2 0
8 3 1 0
9 8 3 0
10 14 2 0
11 10 1 0
12 5 1 0
13 7 1 0
14 17 1 0
15 16 2 0
16 13 1 0
17 13 2 0
18 12 1 0
19 11 1 0
20 11 1 0
21 18 2 0
22 18 1 0
23 22 2 0
24 21 1 0
25 23 1 0
6 5 1 0
15 10 1 0
24 25 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 329.41 | Molecular Weight (Monoisotopic): 329.1640 | AlogP: 3.53 | #Rotatable Bonds: 5 |
Polar Surface Area: 68.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.85 | CX Basic pKa: 4.51 | CX LogP: 4.93 | CX LogD: 4.93 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.73 | Np Likeness Score: -1.33 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |